Silence Therapeutics plc
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Large accelerated filer
State of Incorporation United Kingdom
Country United Kingdom
Business Address 12 HAMMERSMITH GROVE, LONDON, , W6 7AP
Mailing Address 12 HAMMERSMITH GROVE, LONDON, , W6 7AP
Phone 44-0-20-3457 6900
EIN 000000000
Financial Overview
FY2024
$27.22M
Stockholders' Equity
$121.33M
Cash & Equivalents
$-0.33
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | February 13, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 9, 2026 | View on SEC |
| 4 Insider stock transaction report | January 6, 2026 | View on SEC |
| 4 Insider stock transaction report | January 6, 2026 | View on SEC |
| 4 Insider stock transaction report | January 6, 2026 | View on SEC |
| 4 Insider stock transaction report | January 6, 2026 | View on SEC |
| 4 Insider stock transaction report | January 6, 2026 | View on SEC |
| 4 Insider stock transaction report | December 22, 2025 | View on SEC |
| 8-K Current report of material events | December 22, 2025 | View on SEC |
| 8-K/A Current report amendment | December 22, 2025 | View on SEC |
Material Events
8-K Leadership Change December 15, 2025
High Impact
- Silence Therapeutics plc's President and CEO, Craig Tooman, has departed by mutual agreement and stepped down from the Board of Directors.
- Iain Ross, the current Chairman of the Board, has been appointed as interim CEO.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.